Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials

Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists (NDHP, verapamil/diltiazem) in patients suffering from NRP. Eight RCTs with 494 participants were eligible for analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lan, Cheng, Zhong, Gu, Ye, Peng, Dingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609355/
https://www.ncbi.nlm.nih.gov/pubmed/26504804
http://dx.doi.org/10.1155/2015/382086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609355/
https://www.ncbi.nlm.nih.gov/pubmed/26504804
http://dx.doi.org/10.1155/2015/382086

Ejemplares similares